{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:18:02Z","timestamp":1790680682824,"version":"4.1.0"},"reference-count":147,"publisher":"Portland Press Ltd.","issue":"15","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,8,16]]},"abstract":"<jats:p>Impaired wound healing and ulceration caused by diabetes mellitus, is a significant healthcare burden, markedly impairs quality of life for patients, and is the major cause of amputation worldwide. Current experimental approaches used to investigate the complex wound healing process often involve cultures of fibroblasts and\/or keratinocytes in vitro, which can be limited in terms of complexity and capacity, or utilisation of rodent models in which the mechanisms of wound repair differ substantively from that in humans. However, advances in tissue engineering, and the discovery of strategies to reprogramme adult somatic cells to pluripotency, has led to the possibility of developing models of human skin on a large scale. Generation of induced pluripotent stem cells (iPSCs) from tissues donated by diabetic patients allows the (epi)genetic background of this disease to be studied, and the ability to differentiate iPSCs to multiple cell types found within skin may facilitate the development of more complex skin models; these advances offer key opportunities for improving modelling of wound healing in diabetes, and the development of effective therapeutics for treatment of chronic wounds.<\/jats:p>","DOI":"10.1042\/cs20171483","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T10:35:20Z","timestamp":1534242920000},"page":"1629-1643","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The potential of human induced pluripotent stem cells for modelling diabetic wound healing <i>in vitro<\/i>"],"prefix":"10.1042","volume":"132","author":[{"given":"Patricia\u00a0E.","family":"Martin","sequence":"first","affiliation":[{"name":"GCU Skin Research Tissue Bank, Department of Life Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin\u00a0M.","family":"O\u2019Shaughnessy","sequence":"additional","affiliation":[{"name":"GCU Skin Research Tissue Bank, Department of Life Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine\u00a0S.","family":"Wright","sequence":"additional","affiliation":[{"name":"GCU Skin Research Tissue Bank, Department of Life Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Graham","sequence":"additional","affiliation":[{"name":"GCU Skin Research Tissue Bank, Department of Life Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow G4 0BA, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"2021113010554545400_B1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mam.2014.12.004","article-title":"Immunogenetics of type 1 diabetes mellitus","volume":"42","author":"Morran","year":"2015","journal-title":"Mol. Aspects Med."},{"key":"2021113010554545400_B2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00125-016-4162-6","article-title":"Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies","volume":"60","author":"Zaccardi","year":"2017","journal-title":"Diabetologia"},{"key":"2021113010554545400_B3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00125-017-4226-2","article-title":"Precision diabetes: learning from monogenic diabetes","volume":"60","author":"Hattersley","year":"2017","journal-title":"Diabetologia"},{"key":"2021113010554545400_B4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies \u2013 new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"2021113010554545400_B5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-120044","article-title":"Proteomic analysis of the human brain in Huntington\u2019s disease indicates pathogenesis by molecular processes linked to other neurodegenerative diseases and to type-2 diabetes","volume":"2","author":"Schonberger","year":"2013","journal-title":"J. Huntingtons Dis."},{"key":"2021113010554545400_B6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/acn3.439","article-title":"Impact of diabetes in the Friedreich ataxia clinical outcome measures study","volume":"4","author":"McCormick","year":"2017","journal-title":"Annu. Clin. Transl. Neurol."},{"key":"2021113010554545400_B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/MED.0000000000000128","article-title":"Turner syndrome: update on biology and management across the life span","volume":"22","author":"Levitsky","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"2021113010554545400_B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2350-15-16","article-title":"Type II diabetes and impaired glucose tolerance due to severe hyperinsulinaemia in patients with 1p36 deletion syndrome and a Prader-Willi-like phenotype","volume":"15","author":"Stagi","year":"2014","journal-title":"BMC Med. Genet."},{"key":"2021113010554545400_B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrendo.2010.210","article-title":"Alstrom syndrome: insights into the pathogenesis of metabolic disorders","volume":"7","author":"Girard","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"2021113010554545400_B10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3892\/ijmm.2013.1592","article-title":"A cascade leading to premature aging phenotypes including abnormal tumor profiles in Werner syndrome (review)","volume":"33","author":"Sugimoto","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"2021113010554545400_B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0610-7","article-title":"Hutchinson-Gilford Progeria syndrome: a premature aging disease","author":"Ahmed","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"Suppl. 1","key":"2021113010554545400_B12","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.2337\/dc12-s064","article-title":"Diagnosis and classification of diabetes mellitus","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"key":"2021113010554545400_B13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","article-title":"Insulin resistance and hyperglycaemia in cardiovascular disease development","volume":"10","author":"Laakso","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"2021113010554545400_B14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrendo.2013.102","article-title":"Diabetes and its comorbidities \u2013 where East meets West","volume":"9","author":"Kong","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"2021113010554545400_B15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.numecd.2014.02.013","article-title":"Chronic kidney disease in type 2 diabetes: lessions from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study","volume":"24","author":"Pugliese","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"2021113010554545400_B16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.113.002529","article-title":"Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries","volume":"129","author":"Sacks","year":"2014","journal-title":"Circulation"},{"key":"2021113010554545400_B17","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.jdiacomp.2015.06.014","article-title":"Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Programme","volume":"29","author":"Salvotelli","year":"2015","journal-title":"J. Diabetes Complications"},{"key":"2021113010554545400_B18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s12325-014-0140-x","article-title":"Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights","volume":"31","author":"Baltzis","year":"2014","journal-title":"Adv. Ther."},{"key":"2021113010554545400_B19","doi-asserted-by":"publisher","first-page":"385641","DOI":"10.1155\/2013\/385641","article-title":"Current aspects in the pathophysiology and treatment of chronic wounds in diabetes mellitus","volume":"2013","author":"Tsourdi","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"2021113010554545400_B20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann. Med."},{"key":"2021113010554545400_B21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1600-0625.2012.01540.x","article-title":"Animal models of wound repair: are they cutting it?","volume":"21","author":"Ansell","year":"2012","journal-title":"Exp. Dermatol."},{"key":"2021113010554545400_B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2017.12.009","article-title":"Skin wound healing in humans and mice: challenges in translational research","volume":"90","author":"Zomer","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"2021113010554545400_B23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/ten.tec.2014.0414","article-title":"Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds","volume":"21","author":"Maione","year":"2015","journal-title":"Tissue Eng."},{"key":"2021113010554545400_B24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: from hemostasis to wound healing and beyond","volume":"29","author":"Golebiewska","year":"2015","journal-title":"Blood Rev."},{"key":"2021113010554545400_B25","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00018-012-1152-9","article-title":"Cutaneous wound healing: recruiting developmental pathways for regeneration","volume":"70","author":"Bielefeld","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"2021113010554545400_B26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/bjd.13954","article-title":"Cellular and molecular mechanisms of repair in acute and chronic wound healing","volume":"173","author":"Martin","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"2021113010554545400_B27","first-page":"475","article-title":"The physiology of wound healing","volume":"29","author":"Young","year":"2011","journal-title":"Surgery"},{"key":"2021113010554545400_B28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.imbio.2016.08.011","article-title":"Epigenetic mechanisms of macrophage activation in type 2 diabetes","volume":"222","author":"Ahmed","year":"2017","journal-title":"Immunobiology"},{"key":"2021113010554545400_B29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.smim.2014.04.006","article-title":"Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound","volume":"26","author":"Wicks","year":"2014","journal-title":"Semin. Immunol."},{"key":"2021113010554545400_B30","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1242\/dmm.016782","article-title":"Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexity","volume":"7","author":"Nunan","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"2021113010554545400_B31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2174\/157339911797579188","article-title":"Glycoxidation and wound healing in diabetes: an interesting relationship","volume":"7","author":"Peppa","year":"2011","journal-title":"Curr. Diabetes Rev."},{"key":"2021113010554545400_B32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-61779-207-6_2","article-title":"Scratch-wound assay","volume":"769","author":"Cory","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"2021113010554545400_B33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1078\/0171-9335-00428","article-title":"HaCaT keratinocytes secreted lysosomal cysteine proteinases during migration","volume":"83","author":"Buth","year":"2004","journal-title":"Eur. J. Cell Biol."},{"key":"2021113010554545400_B34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ejcb.2007.03.009","article-title":"Cathepsin B is essential for regeneration of scratch-wounded normal human epidermal keratinocytes","volume":"86","author":"Buth","year":"2007","journal-title":"Eur. J. Cell Biol."},{"key":"2021113010554545400_B35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1524-475X.2009.00471.x","article-title":"Connexin mimetic peptides improve cell migration rates of human epidermal keratinocytes and dermal fibroblasts in vitro","volume":"17","author":"Wright","year":"2009","journal-title":"Wound Repair Regen."},{"key":"2021113010554545400_B36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1582-4934.2010.01057.x","article-title":"Connexin 43 mimetic peptide Gap 27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells","volume":"15","author":"Pollok","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"2021113010554545400_B37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jcp.22705","article-title":"The connexin mimetic peptide Gap27 increases human dermal fibroblast migration in hyperglycaemic and hyperinsulinemic conditions in vitro","volume":"227","author":"Wright","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"2021113010554545400_B38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.yexcr.2012.12.013","article-title":"Cell motility in models of wounded human skin is improved by Gap27 despite raised glucose, insulin and IGFBP-5","volume":"319","author":"Wright","year":"2013","journal-title":"Exp. Cell Res."},{"key":"2021113010554545400_B39","doi-asserted-by":"publisher","first-page":"pii: E604","DOI":"10.3390\/ijms19020604","article-title":"The connexin mimetic peptide Gap 27 and Cx43-knockdown reveal differential roles for connexin 43 in wound closure events in skin model systems","volume":"19","author":"Faniku","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"2021113010554545400_B40","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/adhm.201500936","article-title":"Human skin constructs with spatially controlled vasculature using primary and iPSC-derived endothelial cells","volume":"5","author":"Abaci","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"2021113010554545400_B41","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1177\/1535370217712690","article-title":"Next generation human skin constructs as advanced tools for drug development","volume":"242","author":"Abaci","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"2021113010554545400_B42","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/sj.jid.5701125","article-title":"A murine living skin equivalent amenable to live-cell imaging: analysis of the roles of connexins in the epidermis","volume":"128","author":"Kandyba","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"2021113010554545400_B43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000358272","article-title":"Dermal xenobiotic metabolism: a comparison between native human skin, four in vitro skin test systems and a liver system","volume":"27","author":"Wiegland","year":"2014","journal-title":"Skin Pharmacol. Physiol."},{"key":"2021113010554545400_B44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0887-2333(02)00053-X","article-title":"Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics","volume":"16","author":"Faller","year":"2002","journal-title":"Toxicol. In Vitro"},{"key":"2021113010554545400_B45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000066679","article-title":"Permeation and skin absorption: reproducibility of various industrial reconstructed human skin models","volume":"15","author":"Lotte","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"2021113010554545400_B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000066681","article-title":"The use of standardised human skin models for cutaneous pharmacotoxicology studies","volume":"15","author":"Roquet","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"2021113010554545400_B47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000097655","article-title":"Elastin expression in a newly developed full-thickness skin equivalent","volume":"20","author":"Mewes","year":"2007","journal-title":"Skin Pharmcol. Physiol."},{"key":"2021113010554545400_B48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7547\/1000073","article-title":"Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers","volume":"100","author":"Steinberg","year":"2010","journal-title":"J. Am. Pediatr. Med. Assoc."},{"key":"2021113010554545400_B49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4239\/wjd.v6.i1.37","article-title":"Literature review on the management of diabetic foot ulcer","volume":"6","author":"Yazdanpanah","year":"2015","journal-title":"World J. Diabetes"},{"key":"2021113010554545400_B50","first-page":"415","article-title":"A first vascularised skin equivalent as an alternative to animal experimentation","volume":"33","author":"Groeber","year":"2016","journal-title":"ALTEX"},{"key":"2021113010554545400_B51","doi-asserted-by":"publisher","first-page":"e0136713","DOI":"10.1371\/journal.pone.0136713","article-title":"Melanin transfer in human 3D skin equivalents generated exclusively from induced pluripotent stem cells","volume":"10","author":"Gledhill","year":"2015","journal-title":"PLoS ONE"},{"key":"2021113010554545400_B52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1743-6109.2006.00148.x","article-title":"Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study","volume":"14","author":"Hu","year":"2006","journal-title":"Wound Repair Regen."},{"key":"2021113010554545400_B53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.copbio.2009.08.008","article-title":"Tissue-engineered skin substitutes in regenerative medicine","volume":"20","author":"Mansbridge","year":"2009","journal-title":"Curr. Opin. Biotechnol."},{"key":"2021113010554545400_B54","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/026119290703500603","article-title":"The application of normal, SV40 T-antigen-immortalised and tumour-derived oral keratinocytes, under serum-free conditions, to the study of the probability of cancer progression as a result of environmental exposure to chemicals","volume":"35","author":"Ceder","year":"2007","journal-title":"Altern. Lab. Anim."},{"key":"2021113010554545400_B55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/wrr.12148","article-title":"A statistical analysis of murine incisional and excisional acute wound models","volume":"22","author":"Ansell","year":"2014","journal-title":"Wound Repair Regen."},{"key":"2021113010554545400_B56","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00125-015-3562-3","article-title":"Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes","volume":"58","author":"Pane","year":"2015","journal-title":"Diabetologia"},{"key":"2021113010554545400_B57","doi-asserted-by":"publisher","first-page":"9051426","DOI":"10.1155\/2016\/9051426","article-title":"Experimental diabetes mellitus in different animal models","volume":"2016","author":"Al-Awar","year":"2016","journal-title":"J. Diabetes Res."},{"key":"2021113010554545400_B58","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1113\/expphysiol.2011.064220","article-title":"Increased central and peripheral inflammation and inflammatory hyperalgesia in Zucker rat model of leptin receptor deficiency and genetic obesity","volume":"97","author":"Ianitti","year":"2012","journal-title":"Exp. Physiol."},{"key":"2021113010554545400_B59","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/wrr.12305","article-title":"Accelerated healing in NONcNZO10\/LtJ type 2 diabetic mice by FGF-1","volume":"23","author":"Blaber","year":"2015","journal-title":"Wound Repair Regen."},{"key":"2021113010554545400_B60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/wound.2012.0378","article-title":"Strategies demonstrating efficacy in reducing wound contraction","volume":"2","author":"Sharpe","year":"2013","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"2021113010554545400_B61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12079-016-0330-1","article-title":"Cellular mechanisms of skin repair in humans and other mammals","volume":"10","author":"Rittie","year":"2016","journal-title":"J. Cell Commun. Signal."},{"key":"2021113010554545400_B62","first-page":"3","article-title":"Excisional wound healing. An experimental approach","volume":"78","author":"Frank","year":"2003","journal-title":"Methods Mol. Med."},{"key":"2021113010554545400_B63","first-page":"2454026","article-title":"Selective and specific macrophage ablation is detrimental to wound healing in mice","volume":"175","author":"Mirza","year":"2008","journal-title":"Am. J. Pathol."},{"key":"2021113010554545400_B64","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/wrr.12338","article-title":"The murine excisional wound model: contraction revisited","volume":"23","author":"Chen","year":"2010","journal-title":"Wound Repair Regen."},{"key":"2021113010554545400_B65","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jss.2011.07.007","article-title":"A review of the role of mechanical forces in cutaneous wound healing","volume":"171","author":"Agha","year":"2011","journal-title":"J. Surg. Res."},{"key":"2021113010554545400_B66","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/wound.2012.0424","article-title":"Splinting strategies to overcome confounding wound contraction in experimental animal models","volume":"2","author":"Davidson","year":"2013","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"2021113010554545400_B67","doi-asserted-by":"publisher","first-page":"e104447","DOI":"10.1371\/journal.pone.0104447","article-title":"PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds","volume":"9","author":"Park","year":"2014","journal-title":"PLoS ONE"},{"key":"2021113010554545400_B68","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/iwj.12205","article-title":"Utility of a human-mouse xenograft model and in vivo near-infrared fluorescent imaging for studying wound healing","volume":"12","author":"Shanmugam","year":"2015","journal-title":"Int. Wound J."},{"key":"2021113010554545400_B69","first-page":"5","article-title":"Skin bioengineering: preclinical and clinical applications","volume":"103","author":"Martinez-Santamaria","year":"2012","journal-title":"Acta Dermosifiliorgr."},{"key":"2021113010554545400_B70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/exd.12097","article-title":"The regenerative potential of fibroblasts in a new diabetes-induced delayed humanised wound healing model","volume":"22","author":"Martinez-Santamaria","year":"2013","journal-title":"Exp. Dermatol."},{"key":"2021113010554545400_B71","first-page":"327","article-title":"Factors responsible for the abnormal development of embryos obtained by nuclear transplantation in Xenopus laevis","volume":"8","author":"Gurdon","year":"1960","journal-title":"J. Embryol. Exp. Morphol."},{"key":"2021113010554545400_B72","first-page":"505","article-title":"The developmental capacity of nuclei taken from differentiating endoderm cells of Xenopus laevis","volume":"8","author":"Gurdon","year":"1960","journal-title":"J. Embryol. Exp. Morphol."},{"key":"2021113010554545400_B73","first-page":"227","article-title":"The transplantation of nuclei from single cultured cells into enucleate frogs\u2019 eggs","volume":"24","author":"Gurdon","year":"1970","journal-title":"J. Embryol. Exp. Morphol."},{"key":"2021113010554545400_B74","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"2021113010554545400_B75","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1038\/nprot.2007.418","article-title":"Induction of pluripotent stem cells from fibroblast cultures","volume":"2","author":"Takahashi","year":"2007","journal-title":"Nat. Protoc."},{"key":"2021113010554545400_B76","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"2021113010554545400_B77","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"2021113010554545400_B78","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fendo.2017.00276","article-title":"Isogenic cellular systems model the impact of genetic risk variants in the pathogenesis of Type 1 diabetes","volume":"8","author":"Wallet","year":"2017","journal-title":"Front. Endocrinol."},{"key":"2021113010554545400_B79","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: a decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021113010554545400_B80","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2174\/1566524011313050010","article-title":"Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine","volume":"13","author":"Shtrichman","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"2021113010554545400_B81","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.stem.2008.11.008","article-title":"Guidelines and techniques for the generation of induced pluripotent stem cells","volume":"3","author":"Maherali","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2021113010554545400_B82","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/stem.2402","article-title":"Concise review: application of in vitro transcribed messenger RNA for cellular engineering and reprogramming: progress and challenges","volume":"35","author":"Steinle","year":"2017","journal-title":"Stem Cells"},{"key":"2021113010554545400_B83","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2217\/rme.15.79","article-title":"Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells","volume":"11","author":"Hu","year":"2016","journal-title":"Regen. Med."},{"key":"2021113010554545400_B84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12015-015-9622-8","article-title":"Choices for induction of pluripotency: recent developments in human induced pluripotent stem cell reprogramming strategies","volume":"12","author":"Brouwer","year":"2016","journal-title":"Stem Cell Rev."},{"key":"2021113010554545400_B85","first-page":"43","article-title":"Mechanism of induction: induced pluripotent stem cells (iPSCs)","volume":"10","author":"Singh","year":"2015","journal-title":"J. Stem Cells"},{"key":"2021113010554545400_B86","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.scr.2013.03.001","article-title":"Reconsidering pluripotency tests: do we still need teratoma assays?","volume":"11","author":"Buta","year":"2013","journal-title":"Stem. Cell Res."},{"key":"2021113010554545400_B87","doi-asserted-by":"publisher","first-page":"37178","DOI":"10.1038\/srep37178","article-title":"Development of a rapid screen for the endodermal differentiation potential of human pluripotent stem cells","volume":"6","author":"Siller","year":"2016","journal-title":"Sci. Rep."},{"key":"2021113010554545400_B88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1566523211313020004","article-title":"Modelling human disease with pluripotent stem cells","volume":"13","author":"Siller","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"2021113010554545400_B89","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.stemcr.2015.04.001","article-title":"Small-molecule-drive hepatocyte differentiation of human pluripotent stem cells","volume":"4","author":"Siller","year":"2015","journal-title":"Stem Cell Rep."},{"key":"2021113010554545400_B90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","article-title":"Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9","volume":"4","author":"Li","year":"2015","journal-title":"Stem Cell Rep."},{"key":"2021113010554545400_B91","doi-asserted-by":"publisher","first-page":"28614","DOI":"10.3390\/ijms161226119","article-title":"Induced pluripotency and gene editing in disease modelling: perspectives and challenges","volume":"16","author":"Seah","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"2021113010554545400_B92","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-4939-0512-6_16","article-title":"Transdifferentiation of mouse fibroblasts and hepatocytes to functional neurons","volume":"1150","author":"Marro","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"2021113010554545400_B93","doi-asserted-by":"publisher","first-page":"8948","DOI":"10.1073\/pnas.1220637110","article-title":"Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells","volume":"110","author":"Pennarossa","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010554545400_B94","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1038\/ncomms6807","article-title":"Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors","volume":"5","author":"Yang","year":"2014","journal-title":"Nat. Commun."},{"key":"2021113010554545400_B95","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1080\/15384101.2017.1356513","article-title":"Hair follicle-assocated-pluripotent (HAP) stem cells","volume":"16","author":"Amoh","year":"2017","journal-title":"Cell Cycle"},{"key":"2021113010554545400_B96","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13287-015-0089-y","article-title":"Current achievements and future perspectives in whole-organ bioengineering","volume":"6","author":"Peloso","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"2021113010554545400_B97","doi-asserted-by":"publisher","first-page":"a015164","DOI":"10.1101\/cshperspect.a015164","article-title":"Induced pluripotent stem cells in dermatology: potentials, advances and limitations","volume":"4","author":"Bilousova","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2021113010554545400_B98","first-page":"1","article-title":"Differentiation of human induced pluripotent stem cells into a keratinocyte lineage","volume":"1195","author":"Kogut","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"2021113010554545400_B99","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1073\/pnas.1100332108","article-title":"Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells","volume":"108","author":"Itoh","year":"2011","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021113010554545400_B100","doi-asserted-by":"publisher","first-page":"264ra165","DOI":"10.1126\/scitranslmed.3010083","article-title":"Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa","volume":"6","author":"Wenzel","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2021113010554545400_B101","doi-asserted-by":"publisher","first-page":"667","DOI":"10.5021\/ad.2017.29.6.667","article-title":"Current and future perspectives of stem cell therapy in dermatology","volume":"29","author":"Prodinger","year":"2017","journal-title":"Ann. Dermatol."},{"key":"2021113010554545400_B102","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"2021113010554545400_B103","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/nbt.1503","article-title":"Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes","volume":"26","author":"Aasen","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"2021113010554545400_B104","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/nature08285","article-title":"Immortalization eliminates a roadblock during cellular reprogramming into iPS cells","volume":"460","author":"Utikal","year":"2009","journal-title":"Nature"},{"key":"2021113010554545400_B105","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"2021113010554545400_B106","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2008.12.010","article-title":"Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells","volume":"4","author":"Marion","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2021113010554545400_B107","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/stem.404","article-title":"The senescence-related mitochondrial\/oxidative stress pathway is repressed in human induced pluripotent stem cells","volume":"28","author":"Prigione","year":"2010","journal-title":"Stem Cells"},{"key":"2021113010554545400_B108","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1101\/gad.173922.111","article-title":"Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state","volume":"25","author":"Lapasset","year":"2011","journal-title":"Genes Dev."},{"key":"2021113010554545400_B109","doi-asserted-by":"publisher","first-page":"14861","DOI":"10.1073\/pnas.1019070108","article-title":"Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis","volume":"108","author":"Nissan","year":"2011","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021113010554545400_B110","doi-asserted-by":"publisher","first-page":"e17128","DOI":"10.1371\/journal.pone.0017128","article-title":"Epigenetic and phenotype profile of fibroblasts derived from induced pluripotent stem cells","volume":"6","author":"Hewitt","year":"2011","journal-title":"PLoS ONE"},{"key":"2021113010554545400_B111","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12015-017-9737-1","article-title":"Progress and future prospective in skin-on-chip development with emphasis on the use of different cell types and technical challenges","volume":"13","author":"Van den Broek","year":"2017","journal-title":"Stem Cell Rev."},{"key":"2021113010554545400_B112","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/scrt363","article-title":"Building a microphysiological skin model from induced pluripotent stem cells","volume":"4","author":"Guo","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"2021113010554545400_B113","doi-asserted-by":"publisher","first-page":"e77673","DOI":"10.1371\/journal.pone.0077673","article-title":"Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs)","volume":"8","author":"Itoh","year":"2013","journal-title":"PLoS ONE"},{"key":"2021113010554545400_B114","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/jid.2013.7","article-title":"Human induced pluripotent stem cell-derived ectodermal precursor cells contribute to hair follicle morphogenesis in vivo","volume":"133","author":"Veraitch","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"2021113010554545400_B115","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.stemcr.2014.03.009","article-title":"3D in vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells","volume":"2","author":"Petrova","year":"2014","journal-title":"Stem Cell Rep."},{"key":"2021113010554545400_B116","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1089\/ten.tea.2012.0768","article-title":"Cooperation of endothelial and smooth muscle cells derived from human induced pluripotent stem cells enhances neovascularisation in dermal wounds","volume":"19","author":"Kim","year":"2013","journal-title":"Tissue Eng. Part A"},{"key":"2021113010554545400_B117","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/scrt546","article-title":"Exosomes secreted by human-induced pluripotent stell cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice","volume":"6","author":"Hu","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"2021113010554545400_B118","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nmeth.3507","article-title":"Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells","volume":"12","author":"Paull","year":"2015","journal-title":"Nat. Methods"},{"key":"2021113010554545400_B119","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/cell.2015.0009","article-title":"Transcriptome profiling reveals degree of variability in induced pluripotent stem cell lines: impact for human disease modelling","volume":"17","author":"Schuster","year":"2015","journal-title":"Cell Reprogram."},{"key":"2021113010554545400_B120","doi-asserted-by":"publisher","first-page":"8036","DOI":"10.1038\/ncomms9036","article-title":"Limiting replication stress during somatic cell reprogramming reduces genomic inability in induced pluripotent stem cells","volume":"6","author":"Ruiz","year":"2015","journal-title":"Nat. Commun."},{"key":"2021113010554545400_B121","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mrfmmm.2016.01.001","article-title":"Genomic stability during cellular reprogramming: mission impossible?","volume":"788","author":"Von Joest","year":"2016","journal-title":"Mutat. Res."},{"key":"2021113010554545400_B122","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00125-012-2508-2","article-title":"Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation","volume":"55","author":"Fujikura","year":"2012","journal-title":"Diabetologia"},{"key":"2021113010554545400_B123","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41598-018-19264-7","article-title":"Analysis of mitochondrial function in human induced pluripotent stem cells from patients with mitochondrial diabetes due to the A3243G mutation","volume":"8","author":"Matsubara","year":"2018","journal-title":"Sci. Rep."},{"key":"2021113010554545400_B124","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1074\/jbc.C112.428979","article-title":"Derivation of human induced pluripotent stem cells from patients with Maturity Onset Diabetes of the Young","volume":"288","author":"Teo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2021113010554545400_B125","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.scr.2018.02.017","article-title":"Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha (HNF1A) mutation","volume":"29","author":"Griscelli","year":"2018","journal-title":"Stem Cell Res."},{"key":"2021113010554545400_B126","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000000728","article-title":"In vitro generation of glucose-responsive insulin-secreting cells from pancreatic and duodenal homeobox 1-overexpressing human-induced pluripotent stem cell derived from diabetic patient","author":"Rajaei","year":"2017","journal-title":"ASAIO J."},{"key":"2021113010554545400_B127","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.scr.2016.08.005","article-title":"Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene","volume":"17","author":"Wang","year":"2016","journal-title":"Stem Cell Res."},{"key":"2021113010554545400_B128","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stemcr.2016.01.007","article-title":"Early developmental perturbations in a human stem cell model of MODY5\/HNF1B pancreatic hypoplasia","volume":"6","author":"Teo","year":"2016","journal-title":"Stem Cell Rep."},{"key":"2021113010554545400_B129","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/jdi.12334","article-title":"Establishment of maturity-onset diabetes of the young-induced pluripotent stem cells from a Japanese patient","volume":"6","author":"Yabe","year":"2015","journal-title":"J. Diabetes Invest."},{"key":"2021113010554545400_B130","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.scr.2017.07.023","article-title":"Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 13 (MODY13) with a potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) mutation","volume":"23","author":"Griscelli","year":"2018","journal-title":"Stem Cell Res."},{"key":"2021113010554545400_B131","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.scr.2016.12.021","article-title":"Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP gene","volume":"19","author":"Toustrup","year":"2017","journal-title":"Stem Cell Res."},{"key":"2021113010554545400_B132","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.celrep.2017.03.055","article-title":"An activating STAT3 mutation causes neonatal diabetes through premature induction of pancreatic differentiation","volume":"19","author":"Saarimaki-Vire","year":"2017","journal-title":"Cell Rep."},{"key":"2021113010554545400_B133","doi-asserted-by":"publisher","first-page":"22788","DOI":"10.1038\/srep22788","article-title":"Insulin resistance in human iPS cells reduces mitochondrial size and function","volume":"6","author":"Burkart","year":"2016","journal-title":"Sci. Rep."},{"key":"2021113010554545400_B134","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.scr.2016.08.008","article-title":"Induced pluripotent stem cells (iPSC) created from skin fibroblasts of patients with Prader-Willi syndrome (PWS) retain the molecular signature of PWS","volume":"17","author":"Burnett","year":"2016","journal-title":"Stem Cell Res."},{"key":"2021113010554545400_B135","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1042\/BST20110659","article-title":"In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria","volume":"39","author":"Nissan","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"2021113010554545400_B136","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.metabol.2015.12.015","article-title":"Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations","volume":"65","author":"Mori","year":"2016","journal-title":"Metabolism"},{"key":"2021113010554545400_B137","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12727","article-title":"Insulin-producing cells derived from \u2018induced pluripotent stem cells\u2019 of patients with fulminant type 1 diabetes: vulnerability to cytokine insults and increased expression of apoptosis-related genes","author":"Hosokawa","year":"2017","journal-title":"J. Diabetes Invest."},{"key":"2021113010554545400_B138","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3727\/215517914X681785","article-title":"Integration-free human induced pluripotent stem cells from type 1 diabetes patient skin fibroblasts show increased abundance of pancreas-specific microRNAs","volume":"7","author":"Liu","year":"2014","journal-title":"Cell Med."},{"key":"2021113010554545400_B139","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1161\/ATVBAHA.115.306362","article-title":"Three-dimensional vascular network assembly from diabetic patient-derived induced pluripotent stem cells","volume":"35","author":"Chan","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010554545400_B140","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/cell.2015.0087","article-title":"Generation of induced pluripotent stem cells from diabetic foot ulcer fibroblasts using a nonintegrative Sendai virus","volume":"18","author":"Gerami-Naini","year":"2016","journal-title":"Cell Reprogram."},{"key":"2021113010554545400_B141","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.celrep.2014.09.055","article-title":"Disease modelling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells","volume":"9","author":"Drawnel","year":"2014","journal-title":"Cell Rep."},{"key":"2021113010554545400_B142","doi-asserted-by":"publisher","first-page":"926713","DOI":"10.1155\/2014\/926713","article-title":"Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application","volume":"2014","author":"Sun","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"2021113010554545400_B143","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1038\/emm.2016.7","article-title":"Recent progress in genetic and epigenetic research on type 2 diabetes","volume":"48","author":"Kwak","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"2021113010554545400_B144","doi-asserted-by":"publisher","first-page":"e0193949","DOI":"10.1371\/journal.pone.0193949","article-title":"Physiological oxygen culture reveals retention of metabolic memory in human induced pluripotent stem cells","volume":"13","author":"Harvey","year":"2018","journal-title":"PLoS ONE"},{"key":"2021113010554545400_B145","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.12996","article-title":"An arduous journey from human pluripotent stem cells to functional pancreatic \u03b2-cells","volume":"20","author":"Loo","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"2021113010554545400_B146","doi-asserted-by":"publisher","first-page":"20140365","DOI":"10.1098\/rstb.2014.0365","article-title":"Towards consistent generation of pancreatic lineage progenitors from human pluripotent stem cells","volume":"370","author":"Rostovskaya","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"2021113010554545400_B147","doi-asserted-by":"publisher","first-page":"12320","DOI":"10.1038\/s41598-017-12396-2","article-title":"Human iPSC disease modelling reveals functional and structural defects in retinal pigment epithelial cells harbouring the m3243A&gt;G mitochondrial DNA mutation","volume":"7","author":"Chichagova","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/15\/1629\/449349\/cs-2017-1483c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/15\/1629\/449349\/cs-2017-1483c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:47:35Z","timestamp":1638272855000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/132\/15\/1629\/71784\/The-potential-of-human-induced-pluripotent-stem"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":147,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,8,16]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20171483","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]}}}